MEI Pharma, Inc.MEI Pharma, Inc.MEI Pharma, Inc.

MEI Pharma, Inc.

No trades
See on Supercharts
Market capitalization
‪22.05 M‬USD
‪−31.84 M‬USD
‪48.82 M‬USD
‪6.15 M‬
Beta (1Y)
−0.79

About MEI Pharma, Inc.

CEO
David M. Urso
Headquarters
San Diego
Employees (FY)
46
Founded
2000
ISIN
US55279B3015
FIGI
BBG000BSGT68
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MEIP is 3.25 USD — it has decreased by 1.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MEI Pharma, Inc. stocks are traded under the ticker MEIP.
MEI Pharma, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
MEIP stock is 4.00% volatile and has beta coefficient of −0.79. Check out the list of the most volatile stocks — is MEI Pharma, Inc. there?
One year price forecast for MEI Pharma, Inc. has a max estimate of 42.00 USD and a min estimate of 7.00 USD.
MEIP earnings for the last quarter are 8.46 USD whereas the estimation was −1.80 USD which accounts for 571.31% surprise. Estimated earnings for the next quarter are −1.41 USD. See more details about MEI Pharma, Inc. earnings.
MEI Pharma, Inc. revenue for the last quarter amounts to ‪65.30 M‬ USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪100.00 K‬ USD.
Yes, you can track MEI Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
MEIP stock has fallen by 13.79% compared to the previous week, the month change is a 11.68% fall, over the last year MEI Pharma, Inc. has showed a 34.87% decrease.
MEIP net income for the last quarter is ‪−11.06 M‬ USD, while the quarter before that showed ‪56.37 M‬ USD of net income which accounts for −119.62% change. Track more MEI Pharma, Inc. financial stats to get the full picture.
Today MEI Pharma, Inc. has the market capitalization of ‪22.05 M‬, it has decreased by 4.25% over the last week.
Like other stocks, MEIP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEI Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MEIP reached its all-time high on Feb 12, 2004 with the price of 15720.00 USD, and its all-time low was 3.21 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 46.00 employees. See our rating of the largest employees — is MEI Pharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEI Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEI Pharma, Inc. stock shows the sell signal. See more of MEI Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEI Pharma, Inc. future price: according to them, MEIP price has a max estimate of 42.00 USD and a min estimate of 7.00 USD. Read a more detailed MEI Pharma, Inc. forecast: see what analysts think of MEI Pharma, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEI Pharma, Inc. EBITDA is ‪17.35 M‬ USD, and current EBITDA margin is −64.22%. See more stats in MEI Pharma, Inc. financial statements.